Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The role of sentinel node biopsy in gynecological cancer: a review.

Autor: Oonk MH, van de Nieuwenhof HP, de Hullu JA, van der Zee AG

Publikováno v: Current Opinion in Oncology; 2009 Sep, Vol. 21 Issue 5, p425-432, 8p

Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.

Autor: Izquierdo MA, van der Zee AG, Vermorken JB, van der Valk P, Beliën JA, Giaccone G, Scheffer GL, Flens MJ, Pinedo HM, Kenemans P, Izquierdo, M A, van der Zee, A G, Vermorken, J B, van der Valk, P, Beliën, J A, Giaccone, G, Scheffer, G L, Flens, M J, Pinedo, H M, Kenemans, P

Publikováno v: JNCI: Journal of the National Cancer Institute; Aug95, Vol. 87 Issue 16, p1230-1237, 8p

Immunologic aspect of ovarian cancer and p53 as tumor antigen

Autor: van der Burg SH, Lambeck A, Nijman HW, van der Zee AGJ, Daemen T

Publikováno v: Journal of Translational Medicine, Vol 3, Iss 1, p 34 (2005)

Abstract Ovarian cancer represents the fifth leading cause of death from all cancers for women. During the last decades overall survival has improved due to the use of new chemotherapy schedules. Still, the majority of patients die of this disease. R

Externí odkaz: https://doaj.org/article/0e57f521a2354b6b801fb8a7df051c22

Corrigendum to "Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification" [Eur J Cancer 78 (2017) 82-90].

Autor: Eggink FA; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, Groningen, The Netherlands., Mom CH; VU University Medical Center, Center for Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., Bouwman K; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, Groningen, The Netherlands., Boll D; Catharina Hospital, Department of Obstetrics and Gynecology, Eindhoven, The Netherlands., Becker JH; St. Antonius Hospital, Department of Obstetrics and Gynecology, Nieuwegein, The Netherlands., Creutzberg CL; Leiden University Medical Center, Department of Radiation Oncology, Leiden, The Netherlands., Niemeijer GC; University Medical Center Groningen, Department of UMC Staff, Groningen, The Netherlands., van Driel WJ; Antoni van Leeuwenhoek Hospital, Center for Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., Reyners AK; University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Groningen, The Netherlands., van der Zee AG; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, Groningen, The Netherlands., Bremer GL; Zuyderland Medical Center, Department of Obstetrics and Gynecology, Heerlen/Sittard, The Netherlands., Ezendam NP; Netherlands Comprehensive Cancer Organization, Department of Research, Utrecht, The Netherlands., Kruitwagen RF; Maastricht University Medical Center, Department of Obstetrics and Gynecology, Maastricht, The Netherlands; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands., Pijnenborg JM; Radboud University Medical Center Nijmegen, Department of Obstetrics and Gynecology, Nijmegen, The Netherlands., Hollema H; University of Groningen, University Medical Center Groningen, Department of Pathology, Groningen, The Netherlands., Nijman HW; University of Groningen, University Medical Center Groningen, Department of Obstetrics and Gynecology, Groningen, The Netherlands. Electronic address: h.w.nijman@umcg.nl., van der Aa MA; Netherlands Comprehensive Cancer Organization, Department of Research, Utrecht, The Netherlands.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2017 Oct; Vol. 84, pp. 370. Date of Electronic Publication: 2017 Aug 23.